Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
09 May 2014 IMPAKT 2014 News: Adoption of Multi-gene Assays in Hormone Receptor-Positive, HER2-Negative Breast Cancer Breast cancer - Personalised medicine
09 May 2014 IMPAKT 2014 News: Therapeutic Effect and Markers of Response of Palbociclib in HER2-Positive Breast Cancer Models Breast cancer - Translational research - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Enzalutamide With or Without an Aromatase Inhibitor for Advanced Breast Cancer Breast cancer - Translational research
07 May 2014 Molecular Tumour Board Helps in Advanced Cancer Cases Personalised medicine
06 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Denosumab Genitourinary cancers - Palliative and supportive care
05 May 2014 Withdrawal of Application for EMA Change to the Marketing Authorisation of Pazopanib Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Two HPV Vaccines Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies - Gastrointestinal cancers
30 Apr 2014 The Role of Postoperative Radiation Therapy for Endometrial Cancer Gynaecologic malignancies
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
25 Apr 2014 Recommendations for a Molecular Diagnostics Curriculum Personalised medicine - Bioethics, legal and economic issues - Translational research
24 Apr 2014 Biomarker Enrichment Strategies Personalised medicine - Translational research
23 Apr 2014 FDA Approves Ramucirumab for Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Gastrointestinal cancers
22 Apr 2014 European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Anti-Cancer Medicines Identified Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
18 Apr 2014 Does a More Refined Categorisation of Tumour Response and/or Progression Improve Prediction of Overall Survival in RECIST 1.1? Anticancer agents & Biologic therapy